ASCO Guidelines on VTE Add New Oral Agents

November 19, 2019 – Updated venous thromboembolism (VTE) guidelines issued by the American Society of Clinical Oncology (ASCO) now include the use of direct oral anticoagulants (DOACs) for patients with cancer as a preventive measure against VTE recurrence. To develop the new guidelines, an Expert Panel reviewed 35 publications from 2014 through 2018 focusing on VTE prophylaxis and treatment with 26 categorized as metaanalyses and 9 as randomized … (leggi tutto)